欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4781/005
药品名称Quetiapine Accord 150mg prolonged-release Tablets
活性成分
    • quetiapine fumarate 150.0 mg
剂型Prolonged-release tablet
上市许可持有人Accord Healthcare Limited, Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Lithuania (LT)
      Quetiapine Accord 150 mg pailginto atpalaidavimo tabletės
    • Estonia (EE)
      QUETIAPINE ACCORD
    • Hungary (HU)
      QUETIAPINE ACCORD 150 mg retard filmtabletta
    • Cyprus (CY)
    • Romania (RO)
      Quetiapină Accord 150 mg comprimate cu eliberare prelungita
    • Slovakia (SK)
      Quetiapine Accord 150 mg filmom obalené tablety s predĺženým uvoľňovaním
    • Czechia (CZ)
    • United Kingdom (Northern Ireland) (XI)
      Atrolak XL prolonged-release Tablets 150 mg
    • Germany (DE)
      Quetiapin Accord 150 mg Retardtabletten
    • Denmark (DK)
      Quetiapin "Accord"
    • Ireland (IE)
    • Austria (AT)
      Quetiapin Accord 150 mg Retardtabletten
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
      MATEPIL
    • Sweden (SE)
    • Norway (NO)
      Quetiapine Accord
    • Finland (FI)
    • Poland (PL)
      Atrolak
许可日期2016/06/08
最近更新日期2024/08/13
药物ATC编码
    • N05AH04 quetiapine
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase